Tofacitinib for Calcinosis Cutis Associated With Juvenile Dermatomyositis: An Open-Label Single-Arm Study - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Tofacitinib in the Treatment of Calcinosis Cutis Linked to Juvenile Dermatomyositis: Results from an Open-Label Single-Arm Trial

  • By

  • Pragati Jain

  • Supraja Laguduva Mohan

  • Shivani Kaushik

  • Rakesh Deepak

  • Dibyanshu Mishra

  • MA Khan

  • Vishal Gupta

  • Priyanka Naranje

  • AV Ramanan

  • Rakesh Lodha

  • Manisha Jana

  • Narendra Kumar Bagri

  • August 14, 2026

Share

Original Source(s)

Tofacitinib for Calcinosis Cutis Associated With Juvenile Dermatomyositis: An Open-Label Single-Arm Study

  • by Pragati Jain, Supraja Laguduva Mohan, Shivani Kaushik, Rakesh Deepak, Dibyanshu Mishra, MA Khan, Vishal Gupta, Priyanka Naranje, AV Ramanan, Rakesh Lodha, Manisha Jana, Narendra Kumar Bagri

  • August 14, 2026

Related Content

TNFAIP3/A20 dysfunction drives innate and sterile hyperinflammation

Pragmatic evaluation of prescription glucosamine sulfate (pGS) in knee osteoarthritis: insights from a Filipino cohort

Metabolic control of RNA methylation in rheumatoid arthritis: from synovial stress to pathogenic cellular adaptation